首页> 外文期刊>Sexually transmitted diseases >Risk factors for congenital syphilis and adverse pregnancy outcomes in offspring of women with syphilis in Shenzhen, China: A prospective nested case-control study
【24h】

Risk factors for congenital syphilis and adverse pregnancy outcomes in offspring of women with syphilis in Shenzhen, China: A prospective nested case-control study

机译:中国深圳梅毒妇女后代先天性梅毒和不良妊娠结局的危险因素:前瞻性嵌套病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Despite existence of a highly effective intervention, maternal syphilis still causes substantial perinatal morbidity and mortality, even in China, where antenatal health services are strong. This study sought to address personal, programmatic, and other risk factors for congenital syphilis (CS) and adverse pregnancy outcomes (APOs) among pregnant women in Shenzhen, China. METHODS: Pregnant women attending antenatal services were offered serologic tests, and those diagnosed as having syphilis were recruited from April 2007 to October 2012. In a nested case-control study for the pregnancy outcomes of syphilis-infected women, we assessed risk factors comparing infants born with CS (group II) and with any APOs (group III) to infants without CS or APOs (group I). RESULTS: During the 66-month study period, we screened 279,334 pregnant women and identified 838 (0.3%; 95% confidence interval, 0.28%-0.32%) women infected with syphilis. Among infants born to syphilitic mothers, 8.2% (34/417) were diagnosed as having CS and 24.7% (103/417) were diagnosed as having APOs. Compared with group I, maternal baseline titers of nontreponemal antibodies (adjusted odds ratio [aOR], 2.13), stage of syphilis (aOR, 21.56), length of time between the end of the first treatment to childbirth (aOR, 11.93), gestational week at treatment (aOR, 2.63), and fathers' cocaine use (aOR, 15.44) and syphilis infection status (aORpositive vs. negative, 5.84; aORunknown vs. negative, 5.55) were positively associated with CS, but prenatal care (aOR, 0.11) and complete treatment (aOR, 0.20) were negatively associated with CS. Maternal age (aOR, 1.43), marriage (aOR, 2.41), history of cocaine use (aOR, 3.79) and ectopic pregnancy (aOR, 5.91), baseline titers of nontreponemal antibodies (aOR, 1.30), stage of syphilis (aOR, 8.89), length of time between the end of the first treatment to childbirth (aOR, 2.52), gestational week at treatment (aOR, 1.78), and fathers' syphilis infection status (aORunknown vs. negative, 2.02) were also positively associated with APOs, but maternal history of syphilis (aOR, 0.44), prenatal care (aOR, 0.29), and complete treatment (aOR, 0.25) were negatively associated with APOs, CONCLUSIONS: Syphilis was an important cause of pregnancy loss and infant disability, particularly among women who did not receive prenatal care or had late or inadequate treatment. These study results can inform antenatal programs on the importance of early syphilis testing and prompt and appropriate treatment. Some strategies targeted at other risk factors areas may be helpful.
机译:背景:尽管存在高度有效的干预措施,但即使在中国,产前保健服务很强的中国,孕产妇梅毒仍会导致围产期高发病率和高死亡率。本研究旨在探讨中国深圳孕妇先天性梅毒(CS)和不良妊娠结局(APO)的个人,程序和其他风险因素。方法:对接受产前检查的孕妇进行血清学检查,并于2007年4月至2012年10月招募被诊断患有梅毒的孕妇。在一项针对梅毒感染妇女妊娠结局的嵌套病例对照研究中,我们评估了比较婴儿的危险因素没有CS或APO的婴儿(II组)和CS(II组)和任何APO(III组)出生。结果:在为期66个月的研究期内,我们筛查了279,334名孕妇,并确定了838名(0.3%; 95%置信区间为0.28%-0.32%)梅毒感染妇女。在梅毒母亲的婴儿中,8.2%(34/417)被诊断为CS,24.7%(103/417)被诊断为APO。与第一组相比,非三联抗体的母体基线滴度(校正比值比[aOR],2.13),梅毒阶段(aOR,21.56),第一次治疗至分娩之间的时间长度(aOR,11.93),妊娠治疗一周(aOR,2.63),父亲使用可卡因(aOR,15.44)和梅毒感染状态(aOR阳性与阴性,5.84; aOR未知与阴性,5.55)与CS呈正相关,但产前护理(aOR, 0.11)和完全治疗(aOR,0.20)与CS呈负相关。产妇年龄(aOR,1.43),婚姻(aOR,2.41),可卡因使用史(aOR,3.79)和异位妊娠(aOR,5.91),非三联抗体的基线滴度(aOR,1.30),梅毒分期(aOR, 8.89),第一次治疗结束至分娩的时间长度(aOR,2.52),治疗的孕周(aOR,1.78)和父亲的梅毒感染状况(aORunknown vs.阴性,2.02)也与以下因素呈正相关APO,但梅毒的母体病史(aOR,0.44),产前护理(aOR,0.29)和完整治疗(aOR,0.25)与APO呈负相关。结论:梅毒是导致妊娠流产和婴儿残疾的重要原因,特别是那些没有接受产前护理或迟到或治疗不足的妇女中。这些研究结果可以使产前检查计划了解早期梅毒检测以及及时适当治疗的重要性。针对其他风险因素领域的一些策略可能会有所帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号